SIBN
SI-BONE, Inc.
NASDAQ · USHealthcareMedical - Devices
$17.12-1.50%
Price as of Jul 20, 2026
SIBN profitability
SI-BONE, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 79.6%
- EBITDA margin
- -2.9%
- EBIT margin
- -9.7%
- Net margin
- -8.1%
- Free cash flow margin
- -2.7%
Returns
- Return on equity
- -9.3%
- Return on assets
- -6.9%
- Return on invested capital
- -10.7%
- Asset turnover
- 0.86x
Cash efficiency
- Cash from operations
- $1.9M
- Cash per share
- $3.26
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.